News

Filter

Current filters:

None

Popular Filters

7840 to 7864 of 8819 results

US Admin and GPhA moves to prevent drug shortages

18-12-2011

In response to US President Barack Obama’s Executive Order of October 31 (The Pharma Letter November…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Australia’s new PBS prices will drive significant savings, says GMiA

18-12-2011

The new prices for medicines affected by the price disclosure policy on the Australian Pharmaceutical…

Asia-PacificGenericsPharmaceuticalPricing

Brilique first drug to gain post-AMNOG decision in Germany

16-12-2011

The German health assessment body, the Federal Joint Committee (G-BA), has issued its final decision…

BriliqueCardio-vascularEuropePharmaceuticalPricingRegulation

Covidien to spin off pharmaceuticals business

16-12-2011

US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

Where to now for UK Life Sciences?

16-12-2011

The 2012 UK Life Science Industry Leaders Survey* highlights a concern that the UK is losing its position…

BiotechnologyEuropeFinancialPharmaceuticalPricingRegulationResearch

Vertex updates on US and EU Kalydeco filings; to get new CEO

16-12-2011

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) says that the US Food and Drug Administration has…

EuropeKalydecoManagementNorth AmericaPharmaceuticalRare diseasesRegulationVertex

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Isis sees Kynamro delay; adds new drugs to pipeline

15-12-2011

California, USA-based Isis Pharmaceuticals (Nasdaq: ISIS) announced yesterday that there will be a slight…

Cardio-vascularGenzymeIsis PharmaceuticalsKynamromipomersenNephrology and HepatologyPharmaceuticalRegulationResearchSanofi

Intellect Neurosciences appeals European patent decision

15-12-2011

US neuro drug discovery firm Intellect Neurosciences (OTCBB: ILNS) says that it has filed an appeal regarding…

bapineuzumabBiotechnologyElanIntellect NeuroscienceLegalNeurologicalPatentsPfizerPharmaceutical

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Russia’s NSCLC market set to grow to $163 million in 2015

15-12-2011

The Russian market for non-small-cell lung cancer (NSCLC) therapies will grow 3% annually from 2010 to…

EuropeMarkets & MarketingOncologyPharmaceutical

HIV funding in developing countries needs more transparency; report

15-12-2011

With the need for HIV services in developing countries rising and the availability of funding flat or…

Anti-viralsFinancialHealthcarePharmaceutical

Boehringer expands in China; Lundbeckfond ups ALK-Abello stake

15-12-2011

Family-owned German drug major Boehringer Ingelheim says it intends to invest 70 million euros ($91 million)…

Alk-AbelloAsia-PacificBoehringer IngelheimEuropeFinancialLundbeckfondPharmaceutical

FDA advisory panel backs Alexza antipsychotic drug

15-12-2011

The US Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee (PDAC) has voted…

AdasuveAlexza PharmaceuticalFinancialLoxapineNeurologicalPharmaceuticalRegulation

Onyx joins with MMRF to advance MM targeted therapies

15-12-2011

US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) has joined forces with the Multiple Myeloma Research…

BiotechnologyNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalResearch

BioLineRx inks deal with Compugen

14-12-2011

Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Outlook for VTE treatment and prophylaxis market

14-12-2011

Driven primarily by the launches and strong uptake of oral anticoagulants, the combined markets for drugs…

BayerBristol-Myers SquibbCardio-vascularEliquisJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

Australia’s generics sector stresses need for sustainable PBS

14-12-2011

Ensuring the Pharmaceutical Benefits Scheme (PBS) is sustainable and medicines remain affordable and…

Asia-PacificGenericsHealthcarePoliticsPricing

Global ADHD market set to grow at a CAGR of 8% to 2018

14-12-2011

The global attention deficit hyperactivity disorder (ADHD) therapeutics market was valued at $3.86 billion…

DaytranaGlobalIntunivMarkets & MarketingNeurologicalPharmaceuticalShireVyvanse

FTC stipulates divestments for Valeant acquisitions

14-12-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Baxter to acquire Synovis

14-12-2011

The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

7840 to 7864 of 8819 results

Back to top